Results 161 to 170 of about 1,207,125 (312)

Hippo pathway at the crossroads of stemness and therapeutic resistance in breast cancer

open access: yesMolecular Oncology, EarlyView.
Dysregulation of the Hippo pathway drives nuclear accumulation of YAP/TAZ, activating stemness‐related transcriptional programs that sustain breast cancer stemness and fuel therapeutic resistance across subtypes, underscoring Hippo signaling as a targetable vulnerability. Figure created and edited with BioRender.com.
Giulia Schiavoni   +11 more
wiley   +1 more source

Therapeutic Targeting in Ovarian Cancer: Nano-Enhanced CRISPR/Cas9 Gene Editing and Drug Combination Therapy [PDF]

open access: yes
Hong-Kook Kim,1,2 Heedon Cheong,3 Moo-Yeon Kim,3 Hyo-Eon Jin2,3 1AI-Super Convergence KIURI Translational Research Center, Ajou University, Suwon, 16499, Republic of Korea; 2Research Institute of Pharmaceutical Science and Technology, Ajou University ...
Cheong H, Kim HK, Kim MY, Jin HE
core   +1 more source

Precise and heritable gene targeting in rice using a sequential transformation strategy. [PDF]

open access: yesCell Rep Methods, 2023
Zhang W   +13 more
europepmc   +1 more source

Deciphering transcriptional plasticity in pancreatic ductal adenocarcinoma reveals alterations in sensory neuron innervation

open access: yesMolecular Oncology, EarlyView.
Pancreatic sensory neurons innervating healthy and PDAC tissue were retrogradely labeled and profiled by single‐cell RNA sequencing. Tumor‐associated innervation showed a dominant neurofilament‐positive subtype, altered mitochondrial gene signatures, and reduced non‐peptidergic neurons.
Elena Genova   +14 more
wiley   +1 more source

Differential expression of cancer‐related genes supports prediction of poor response to first‐line treatments in T‐ALL pediatric patients with high minimal residual disease

open access: yesMolecular Oncology, EarlyView.
In the present work, we have identified a transcriptional signature based on the differential expression of six genes (BCL2&MAST4, HSH2D&LAT2, METRN&PITPNM2) that would facilitate the early detection of T‐cell acute lymphoblastic leukemia (T‐ALL) patients prone to a poor treatment response and could be implemented at diagnosis, along with other risk ...
Antonio Lahera   +11 more
wiley   +1 more source

Gene targeting as a therapeutic avenue in diseases mediated by the complement alternative pathway. [PDF]

open access: yesImmunol Rev, 2023
Dreismann AK   +6 more
europepmc   +1 more source

CCDC80 suppresses high‐grade serous ovarian cancer migration via negative regulation of B7‐H3

open access: yesMolecular Oncology, EarlyView.
PAX8 is a lineage‐specific master regulator of transcription in high‐grade serous ovarian cancer (HGSC) progression. We show for the first time that PAX8 facilitates proliferation and metastasis by repressing the cell autonomous tumor suppressor CCDC80 and inducing B7‐H3 expression.
Aya Saleh   +12 more
wiley   +1 more source

Bioinformatics driven in gene targeting platform for gold anticancer strategy delivery. [PDF]

open access: yesMater Today Bio
Jiang C   +9 more
europepmc   +1 more source

Combinatorial gene targeting in primary human hematopoietic stem and progenitor cells. [PDF]

open access: yesSci Rep, 2022
Bäckström A   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy